Evidence map›Paper›PMID 41458276›Full record

ArticleOxford medical case reports2025

Complexities of Bartter Syndrome Type III: A Case Study in Jordan.

Hamdah Hanifa, Yumna Al-Badareen, Malak Mbarak Al-Refaai, Nafeaa M Ganama, Mohammad Sameeh Alabrash, Basil Alsaleh

Abstract readCase Reports
In one paragraph

Article in Oxford medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hamdah HanifaFaculty of Medicine, University of Kalamoon, Al-Nabk, Syria.ORCID https://orcid.org/0000-0003-2970-7379
Yumna Al-BadareenFaculty of Medicine, Mutah University, Karak, Jordan.
Malak Mbarak Al-RefaaiFaculty of Medicine, University of Kalamoon, Al-Nabk, Syria.
Nafeaa M GanamaFaculty of Medicine, University of Kalamoon, Al-Nabk, Syria.
Mohammad Sameeh AlabrashFaculty of Dentistry, Al-Wataniya Private University, Hama, Syria.
Basil AlsalehFaculty of Medicine, Tbilisi State Medical University, Tbilisi, Georgia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bartter Syndrome (BS) is a genetic disorder affecting the renal tubules, leading to elevated levels of renin, angiotensin, and aldosterone, along with metabolic alkalosis, while maintaining normal blood pressure. It is also associated with laboratory abnormalities such as hypocalcemia, hypokalemia, hypomagnesemia, and hyponatremia, which may result in neurological complications including seizures and loss of consciousness. These findings necessitate consideration of important differential diagnoses such as Gitelman syndrome and cystic fibrosis, underscoring the importance of confirming the diagnosis of this serious condition, giving it appropriate attention, and initiating early treatment to prevent advanced complications. We report the case of a 36-year-old Jordanian male with a medical history of Bartter Syndrome and chronic kidney disease, who presented to the emergency department in a coma with generalized seizures due to severe electrolyte imbalances. His condition was further complicated by a genetic predisposition and a family history of Bartter Syndrome, with genetic testing confirming mutations in the CLCNKB gene. This rare case of Bartter Syndrome type III, in which the patient progressed to the stage of hemodialysis, illustrates the complexities of diagnosis and management, and emphasizes the importance of continuous care and regular follow-up.

Indexed as

Antenatal Bartter SyndromeBartter SyndromeChronic Kidney DiseaseClassical Bartter SyndromeCLCNKBLoop of Henle

Identifiers

PMID41458276
PMCPMC12741425

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.